Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 38

1.

Evaluation of Patients With a History of Penicillin Allergy-Reply.

Shenoy ES, Blumenthal KG.

JAMA. 2019 Jun 18;321(23):2367. doi: 10.1001/jama.2019.4542. No abstract available.

PMID:
31211341
2.

Clinical decision support improved allergy documentation of antibiotic test dose results.

Wright A, Rubins D, Shenoy ES, Wickner PG, McEvoy D, Wolfson AR, Carballo VA, Blumenthal KG.

J Allergy Clin Immunol Pract. 2019 May 25. pii: S2213-2198(19)30475-1. doi: 10.1016/j.jaip.2019.04.052. [Epub ahead of print] No abstract available.

PMID:
31136821
3.

Is My Child Allergic to Penicillin?

Blumenthal KG, Shenoy ES.

JAMA Pediatr. 2019 May 28. doi: 10.1001/jamapediatrics.2019.1402. [Epub ahead of print] No abstract available.

PMID:
31135810
4.

Outcomes from an inpatient beta-lactam allergy guideline across a large US health system.

Blumenthal KG, Li Y, Hsu JT, Wolfson AR, Berkowitz DN, Carballo VA, Schwartz JM, Marquis KA, Elshaboury R, Gandhi RG, Lambl BB, Freeley MM, Gruszecki A, Wickner PG, Shenoy ES.

Infect Control Hosp Epidemiol. 2019 May;40(5):528-535. doi: 10.1017/ice.2019.50. Epub 2019 Mar 27.

5.

The Special Pathogens Research Network: Enabling Research Readiness.

Kraft CS, Kortepeter MG, Gordon B, Sauer LM, Shenoy ES, Eiras DP, Larson L, Garland JA, Mehta AK, Barrett K, Price CS, Croyle C, West LR, Noren B, Kline S, Arguinchona C, Arguinchona H, Grein JD, Connally C, McLellan S, Risi GF, Uyeki TM, Davey RT Jr, Schweinle JE, Schwedhelm MM, Harvey M, Hunt RC, Kratochvil CJ.

Health Secur. 2019 Jan/Feb;17(1):35-45. doi: 10.1089/hs.2018.0106.

PMID:
30779607
6.

Evaluation and Management of Penicillin Allergy: A Review.

Shenoy ES, Macy E, Rowe T, Blumenthal KG.

JAMA. 2019 Jan 15;321(2):188-199. doi: 10.1001/jama.2018.19283. Review.

PMID:
30644987
7.

Am I Allergic to Penicillin?

Blumenthal KG, Shenoy ES.

JAMA. 2019 Jan 15;321(2):216. doi: 10.1001/jama.2018.20470. No abstract available.

PMID:
30644984
8.

Transmission of Mobile Colistin Resistance (mcr-1) by Duodenoscope.

Shenoy ES, Pierce VM, Walters MS, Moulton-Meissner H, Lawsin A, Lonsway D, Shugart A, McAllister G, Halpin AL, Zambrano-Gonzalez A, Ryan EE, Suslak D, DeJesus A, Barton K, Madoff LC, McHale E, DeMaria A, Hooper DC.

Clin Infect Dis. 2019 Apr 8;68(8):1327-1334. doi: 10.1093/cid/ciy683.

PMID:
30204838
9.

Reply to Vaisman et al.

Blumenthal KG, Shenoy ES.

Clin Infect Dis. 2018 Nov 28;67(12):1960-1961. doi: 10.1093/cid/ciy481. No abstract available.

PMID:
29878135
10.

Real-Time, Automated Detection of Ventilator-Associated Events: Avoiding Missed Detections, Misclassifications, and False Detections Due to Human Error.

Shenoy ES, Rosenthal ES, Shao YP, Biswal S, Ghanta M, Ryan EE, Suslak D, Swanson N, Junior VM, Hooper DC, Westover MB.

Infect Control Hosp Epidemiol. 2018 Jul;39(7):826-833. doi: 10.1017/ice.2018.97. Epub 2018 May 17.

PMID:
29769151
11.

A Generalizable, Data-Driven Approach to Predict Daily Risk of Clostridium difficile Infection at Two Large Academic Health Centers.

Oh J, Makar M, Fusco C, McCaffrey R, Rao K, Ryan EE, Washer L, West LR, Young VB, Guttag J, Hooper DC, Shenoy ES, Wiens J.

Infect Control Hosp Epidemiol. 2018 Apr;39(4):425-433. doi: 10.1017/ice.2018.16.

12.

The Impact of a Reported Penicillin Allergy on Surgical Site Infection Risk.

Blumenthal KG, Ryan EE, Li Y, Lee H, Kuhlen JL, Shenoy ES.

Clin Infect Dis. 2018 Jan 18;66(3):329-336. doi: 10.1093/cid/cix794.

13.

Outbreak Response and Incident Management: SHEA Guidance and Resources for Healthcare Epidemiologists in United States Acute-Care Hospitals.

Banach DB, Johnston BL, Al-Zubeidi D, Bartlett AH, Bleasdale SC, Deloney VM, Enfield KB, Guzman-Cottrill JA, Lowe C, Ostrosky-Zeichner L, Popovich KJ, Patel PK, Ravin K, Rowe T, Shenoy ES, Stienecker R, Tosh PK, Trivedi KK; Outbreak Response Training Program (ORTP) Advisory Panel.

Infect Control Hosp Epidemiol. 2017 Dec;38(12):1393-1419. doi: 10.1017/ice.2017.212. Epub 2017 Nov 30. No abstract available.

PMID:
29187263
14.

Machine Learning for Healthcare: On the Verge of a Major Shift in Healthcare Epidemiology.

Wiens J, Shenoy ES.

Clin Infect Dis. 2018 Jan 6;66(1):149-153. doi: 10.1093/cid/cix731.

15.

A Discrete Event Simulation Model of Patient Flow in a General Hospital Incorporating Infection Control Policy for Methicillin-Resistant Staphylococcus Aureus (MRSA) and Vancomycin-Resistant Enterococcus (VRE).

Shenoy ES, Lee H, Ryan EE, Hou T, Walensky RP, Ware W, Hooper DC.

Med Decis Making. 2018 Feb;38(2):246-261. doi: 10.1177/0272989X17713474. Epub 2017 Jun 29.

16.

Addressing Inpatient Beta-Lactam Allergies: A Multihospital Implementation.

Blumenthal KG, Shenoy ES, Wolfson AR, Berkowitz DN, Carballo VA, Balekian DS, Marquis KA, Elshaboury R, Gandhi RG, Meka P, Kubiak DW, Catella J, Lambl BB, Hsu JT, Freeley MM, Gruszecki A, Wickner PG.

J Allergy Clin Immunol Pract. 2017 May - Jun;5(3):616-625.e7. doi: 10.1016/j.jaip.2017.02.019. Review.

17.

Tackling inpatient penicillin allergies: Assessing tools for antimicrobial stewardship.

Blumenthal KG, Wickner PG, Hurwitz S, Pricco N, Nee AE, Laskowski K, Shenoy ES, Walensky RP.

J Allergy Clin Immunol. 2017 Jul;140(1):154-161.e6. doi: 10.1016/j.jaci.2017.02.005. Epub 2017 Feb 28.

18.

The Impact of Reporting a Prior Penicillin Allergy on the Treatment of Methicillin-Sensitive Staphylococcus aureus Bacteremia.

Blumenthal KG, Shenoy ES, Huang M, Kuhlen JL, Ware WA, Parker RA, Walensky RP.

PLoS One. 2016 Jul 20;11(7):e0159406. doi: 10.1371/journal.pone.0159406. eCollection 2016.

19.

Editorial Commentary: Fortune Favors the Bold: Give a Beta-Lactam!

Blumenthal KG, Shenoy ES.

Clin Infect Dis. 2016 Oct 1;63(7):911-3. doi: 10.1093/cid/ciw467. Epub 2016 Jul 11. No abstract available.

PMID:
27402818
20.

Adverse Drug Reactions Associated with Ceftaroline Use: A 2-Center Retrospective Cohort.

Blumenthal KG, Kuhlen JL Jr, Weil AA, Varughese CA, Kubiak DW, Banerji A, Shenoy ES.

J Allergy Clin Immunol Pract. 2016 Jul-Aug;4(4):740-6. doi: 10.1016/j.jaip.2016.03.008. Epub 2016 Apr 27.

21.

The Impact of Methicillin-Resistant Staphylococcus aureus (MRSA) and Vancomycin-Resistant Enterococcus (VRE) Flags on Hospital Operations.

Shenoy ES, Lee H, Hou T, Ware W, Ryan EE, Hooper DC, Walensky RP.

Infect Control Hosp Epidemiol. 2016 Jul;37(7):782-90. doi: 10.1017/ice.2016.54. Epub 2016 Mar 29.

22.

CASE RECORDS of the MASSACHUSETTS GENERAL HOSPITAL. Case 39-2015. A 22-Year-Old Man with Hypoxemia and Shock.

Shenoy ES, Lai PS, Shepard JA, Kradin RL.

N Engl J Med. 2015 Dec 17;373(25):2456-66. doi: 10.1056/NEJMcpc1507212. No abstract available.

PMID:
26672848
23.

Impact of rapid screening for discontinuation of methicillin-resistant Staphylococcus aureus contact precautions.

Shenoy ES, Lee H, Cotter JA, Ware W, Kelbaugh D, Weil E, Walensky RP, Hooper DC.

Am J Infect Control. 2016 Feb;44(2):215-21. doi: 10.1016/j.ajic.2015.08.019. Epub 2015 Oct 2.

24.

CASE RECORDS of the MASSACHUSETTS GENERAL HOSPITAL. Case 28-2015. A 32-Year-Old Man with Fever, Headache, and Myalgias after Traveling from Liberia.

Biddinger PD, Hooper DC, Shenoy ES, Bajwa EK, Robbins GK, Branda JA.

N Engl J Med. 2015 Sep 10;373(11):1060-7. doi: 10.1056/NEJMcpc1503828. No abstract available.

PMID:
26352818
25.

Housestaff Knowledge Related to Urinary Catheter Use and Catheter-Associated Urinary Tract Infections.

Paras ML, Shenoy ES, Hsu HE, Walensky RP, Hooper DC.

Infect Control Hosp Epidemiol. 2015 Nov;36(11):1355-7. doi: 10.1017/ice.2015.189. Epub 2015 Aug 17.

26.

Impact of a clinical guideline for prescribing antibiotics to inpatients reporting penicillin or cephalosporin allergy.

Blumenthal KG, Shenoy ES, Varughese CA, Hurwitz S, Hooper DC, Banerji A.

Ann Allergy Asthma Immunol. 2015 Oct;115(4):294-300.e2. doi: 10.1016/j.anai.2015.05.011. Epub 2015 Jun 9.

27.

Ceftaroline desensitization procedure in a pregnant patient with multiple drug allergies.

Kuhlen JL Jr, Blumenthal KG, Sokol CL, Balekian DS, Weil AA, Varughese CA, Shenoy ES, Banerji A.

Open Forum Infect Dis. 2015 Mar 23;2(1):ofv027. doi: 10.1093/ofid/ofv027. eCollection 2015 Jan.

28.

Improving Clinical Outcomes in Patients With Methicillin-Sensitive Staphylococcus aureus Bacteremia and Reported Penicillin Allergy.

Blumenthal KG, Parker RA, Shenoy ES, Walensky RP.

Clin Infect Dis. 2015 Sep 1;61(5):741-9. doi: 10.1093/cid/civ394. Epub 2015 May 19.

29.

An electronic surveillance tool for catheter-associated urinary tract infection in intensive care units.

Hsu HE, Shenoy ES, Kelbaugh D, Ware W, Lee H, Zakroysky P, Hooper DC, Walensky RP.

Am J Infect Control. 2015 Jun;43(6):592-9. doi: 10.1016/j.ajic.2015.02.019. Epub 2015 Mar 31.

30.

Effect of a drug allergy educational program and antibiotic prescribing guideline on inpatient clinical providers' antibiotic prescribing knowledge.

Blumenthal KG, Shenoy ES, Hurwitz S, Varughese CA, Hooper DC, Banerji A.

J Allergy Clin Immunol Pract. 2014 Jul-Aug;2(4):407-13. doi: 10.1016/j.jaip.2014.02.003. Epub 2014 Apr 24.

31.

Comparative evaluation of the tolerability of cefazolin and nafcillin for treatment of methicillin-susceptible Staphylococcus aureus infections in the outpatient setting.

Youngster I, Shenoy ES, Hooper DC, Nelson SB.

Clin Infect Dis. 2014 Aug 1;59(3):369-75. doi: 10.1093/cid/ciu301. Epub 2014 Apr 29.

32.

Natural history of colonization with methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus (VRE): a systematic review.

Shenoy ES, Paras ML, Noubary F, Walensky RP, Hooper DC.

BMC Infect Dis. 2014 Mar 31;14:177. doi: 10.1186/1471-2334-14-177. Review.

33.

Tolerability of cefazolin after immune-mediated hypersensitivity reactions to nafcillin in the outpatient setting.

Blumenthal KG, Youngster I, Shenoy ES, Banerji A, Nelson SB.

Antimicrob Agents Chemother. 2014 Jun;58(6):3137-43. doi: 10.1128/AAC.02504-13. Epub 2014 Mar 17.

34.

Concordance of PCR and culture from nasal swabs for detection of methicillin-resistant Staphylococcus aureus in a setting of concurrent antistaphylococcal antibiotics.

Shenoy ES, Noubary F, Kim J, Rosenberg ES, Cotter JA, Lee H, Walensky RP, Hooper DC.

J Clin Microbiol. 2014 Apr;52(4):1235-7. doi: 10.1128/JCM.02972-13. Epub 2014 Jan 22.

35.

Discontinuation of contact precautions for methicillin-resistant staphylococcus aureus: a randomized controlled trial comparing passive and active screening with culture and polymerase chain reaction.

Shenoy ES, Kim J, Rosenberg ES, Cotter JA, Lee H, Walensky RP, Hooper DC.

Clin Infect Dis. 2013 Jul;57(2):176-84. doi: 10.1093/cid/cit206. Epub 2013 Apr 9.

36.

National survey of infection preventionists: policies for discontinuation of contact precautions for methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococcus.

Shenoy ES, Hsu H, Noubary F, Hooper DC, Walensky RP.

Infect Control Hosp Epidemiol. 2012 Dec;33(12):1272-5. doi: 10.1086/668427. Epub 2012 Oct 26. No abstract available.

37.

Resource burden associated with contact precautions for methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus: the patient access managers' perspective.

Shenoy ES, Walensky RP, Lee H, Orcutt B, Hooper DC.

Infect Control Hosp Epidemiol. 2012 Aug;33(8):849-52. doi: 10.1086/666629. Epub 2012 Jun 26.

38.

Natalizumab and HSV meningitis.

Shenoy ES, Mylonakis E, Hurtado RM, Venna N.

J Neurovirol. 2011 Jun;17(3):288-90. doi: 10.1007/s13365-011-0027-4. Epub 2011 Apr 13.

Supplemental Content

Loading ...
Support Center